India’s Bharat Biotech says its Covaxin booster dose offers long-term protection | Inquirer News
Close  

India’s Bharat Biotech says its Covaxin booster dose offers long-term protection

/ 10:28 PM January 08, 2022
COVID-19 vaccination in New Delhi

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech’s COVID-19 vaccine called Covaxin during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, Jan. 16, 2021. (REUTERS)

India’s Bharat Biotech said on Saturday a booster dose of its COVID-19 vaccine Covaxin offered long-term protection from severe disease in a trial.

The company said a booster dose was given to trial participants six months after they received their second dose.

ADVERTISEMENT

FEATURED STORIES

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Bharat Biotech Covaxin, COVID-19 Vaccines
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.